Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 84106

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 21, 2019
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.

D-0154-2020
Recall number
D-0154-2020
Initiated
October 21, 2019
Classification
Class III
Status
Terminated
Quantity
19,390 syringes

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
labeling: Incorrect or missing

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Incorrect labeling: Incorrect or missing lot and/or exp date

Code information

Lots: SU9079A, SU9079B, Exp 4/5/2020

Distribution pattern

Nationwide in the U.S.